Repeated Implantation Failure
11
3
3
5
Key Insights
Highlights
Success Rate
100% trial completion (above average)
Clinical Risk Assessment
Based on trial outcomes
Moderate Risk
Score: 50/100
0.0%
0 terminated out of 11 trials
100.0%
+13.5% vs benchmark
0%
0 trials in Phase 3/4
0%
0 of 5 completed with results
Key Signals
Data Visualizations
Phase Distribution
Trial Status
Trial Success Rate
Benchmark: 86.5%
Based on 5 completed trials
Clinical Trials (11)
Effect of Acupuncture on IVF Pregnancy Outcomes for Women With RIF
The Clinical Efficiency of Tb-ERA in Chinese RIF Patients
Application of Platelet-rich Plasma (PRP) in Reproductive Medicine
Uterine Microbiome in Women with Repeated Implantation Failure and Normal Fertile Women
Uterine Natural Killer (uNK) Cell Expression in Patients With Repeated ICSI Failures: A Multicenter Cohort Study
Establishment of the Human Intestinal and Salivary Microbiota Biobank - Gynecological Diseases
Intrauterine Injection of Human Chorionic Gonadotrophin and Pregnancy Rate in ICSI
The Study of the Relationship Between TWEAK/Fn14, JAK/STAT3 and IDO in the Immune Microenvironment of Endometrium in Repeated Implantation Failure
A Randomized Double Blind Comparison of Atosiban in Patients With RIF Undergoing IVF Treatment
Follicular Versus Luteal Pipelle in Repeated Implantation Failure Patients
Atosiban Improves Implantation and Pregnancy Rates in Patients With Repeated Implantation Failure